A phenotypic high-throughput screening assay for the pharmacological inhibition of the pathological deposition of extracellular matrix

G. Burgstaller (Munich, Germany)

Source: ERS Lung Science Conference 2018
Number: 3

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Burgstaller (Munich, Germany). A phenotypic high-throughput screening assay for the pharmacological inhibition of the pathological deposition of extracellular matrix. ERS Lung Science Conference 2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A phenotypic cell-based extracellular matrix deposition assay for target validation and drug discovery
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Time-resolved proteomic characterization of ECM remodelling in human lung scaffold cultures using stable isotope labelling
Source: ERS Lung Science Conference 2018
Year: 2018

In vivo pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-α converting enzyme and matrix metalloproteinases, in models of airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 169s
Year: 2002

Eosinophils contribute to extracellular matrix remodeling by enhancing pulmonary fibroblasts proliferation, differentiation and extracellular matrix proteins production in asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Identification of pleural infection microbiological patterns by applying next generation sequencing and bioinformatics analysis
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020



Composition of the cellular matrix, nutrition, and hypoxia modulate the secretion and activation of collagenases and their inhibitors in human lung cells
Source: Eur Respir J 2001; 18: Suppl. 33, 244s
Year: 2001

Modern molecular direct tests for rapid identification and drug susceptibility testing of Mycobacterium tuberculosis
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012

The activity of the inflammatory process and markers of an extracellular matrix destruction in pulmonary tuberculoma
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


An innovative high sensitivity tool for active neutrophil elastase quantification
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


Microcrystalline cellulose induces time-dependent lung functional, morphological and inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 348s
Year: 2006

Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres
Source: ERJ Open Res, 7 (1) 00658-2020; 10.1183/23120541.00658-2020
Year: 2021



A rapid method to increase the clinical use of sputum inflammatory cells
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017




BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Pirfenidone induced inhibition of p38 downregulates procoagulant microparticle generation by human alveolar epithelia cells
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells
Source: Eur Respir J, 59 (1) 2100285; 10.1183/13993003.00285-2021
Year: 2022



Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004

Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension
Source: ERS Lung Science Conference 2018
Year: 2018